abstract |
The invention relates to novel tetrahydroquinoxalines of structure I/Ia, to a method for producing the same and to the use thereof for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of painful conditions. The compounds have an affinity to the bradykinin-1 receptor. |